Raia Drogasil S.A.
RADLY
$4.48
$0.010.22%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.66% | -1.69% | -0.31% | 6.03% | 12.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.66% | -1.69% | -0.31% | 6.03% | 12.31% |
| Cost of Revenue | 2.38% | -1.06% | 0.28% | 6.55% | 12.68% |
| Gross Profit | -0.03% | -3.18% | -1.68% | 4.84% | 11.44% |
| SG&A Expenses | 0.69% | -2.98% | -1.24% | 3.92% | 11.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 98.88% | 64.34% | 72.24% | 99.09% | -168.45% |
| Total Operating Expenses | 2.27% | -1.34% | 0.16% | 6.29% | 12.19% |
| Operating Income | -7.27% | -7.04% | -7.17% | 2.16% | 14.00% |
| Income Before Tax | -8.35% | -10.03% | -7.98% | 7.69% | 14.39% |
| Income Tax Expenses | -77.87% | -65.18% | -31.39% | 55.51% | 136.06% |
| Earnings from Continuing Operations | 9.42% | 1.51% | -3.42% | 1.95% | 1.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 44.71% | 57.81% | 79.96% | 65.82% | -65.26% |
| Net Income | 10.86% | 3.20% | -1.09% | 4.03% | 0.04% |
| EBIT | -7.27% | -7.04% | -7.17% | 2.16% | 14.00% |
| EBITDA | -5.64% | -6.01% | -6.55% | 1.74% | 11.78% |
| EPS Basic | 28.16% | 20.63% | -11.78% | -6.00% | -11.02% |
| Normalized Basic EPS | -5.17% | 4.22% | -17.37% | -4.33% | 7.28% |
| EPS Diluted | 28.11% | 20.50% | -11.81% | -6.09% | -11.07% |
| Normalized Diluted EPS | -5.30% | 3.99% | -17.40% | -4.45% | 7.19% |
| Average Basic Shares Outstanding | -16.39% | -16.78% | 16.13% | 15.06% | 16.06% |
| Average Diluted Shares Outstanding | -16.31% | -16.64% | 16.07% | 14.87% | 15.83% |
| Dividend Per Share | -38.54% | 13.32% | -36.31% | -63.79% | 213.81% |
| Payout Ratio | -0.09% | -0.02% | -0.08% | -0.12% | 0.05% |